Clinical utility of circulating tumor DNA as a response and follow-up marker in cancer therapy

Response evaluation for cancer treatment consists primarily of clinical and radiological assessments. In addition, a limited number of serum biomarkers that assess treatment response are available for a small subset of malignancies. Through recent technological innovations, new methods for measuring...

Descripción completa

Detalles Bibliográficos
Autores principales: Boonstra, Pieter A., Wind, Thijs T., van Kruchten, Michel, Schuuring, Ed, Hospers, Geke A. P., van der Wekken, Anthonie J., de Groot, Derk-Jan, Schröder, Carolien P., Fehrmann, Rudolf S. N., Reyners, Anna K. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497299/
https://www.ncbi.nlm.nih.gov/pubmed/32367253
http://dx.doi.org/10.1007/s10555-020-09876-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497299/
https://www.ncbi.nlm.nih.gov/pubmed/32367253
http://dx.doi.org/10.1007/s10555-020-09876-9

Ejemplares similares